Societe Pharmaceutique Du Rwanda Limited (SOPHAR), a privately owned company founded in 2007, distributes generic and brand named drugs and medical consumables in Rwanda. In 2012, SOPHAR received funding through a strategic partnership with Fanisi Capital Investment Fund based in Nairobi, Kenya. In 2013, SOPAHR launched the construction of a warehousing project at the Special Economic Zone in Kigali where its Headquarters are now currently located.
The pharmaceutical industry is ever changing, shadowing the changes in our environment. Understanding and countering these changes with new and improved products is the day to day challenge that affects the pharmaceutical industry. In the forefront of change is technology; breakthrough in science has greatly affected the industry and products.
Pharmaceutical customers are General Practitioners and patients. At present, only 1% of the population live more than 5KM from a Health Facility.[1] In 2012, the Rwanda Population was 10.5 million, of these 4.87% or slightly above half a million people (511,738) were over the age of 60.[2] It is noted that the number of elderly people has more than doubled since 1978. At present, Community Based Health Insurance Policy, based on stratified payment of premiums was operationalised in 2011. It is reported that, 86% of the categorised population were covered by health insurance.[3]
[1] Fourth Population and Housing Census, Rwanda 2012,Page 26
2 Fourth Population and Housing Census, Rwanda 2012, Page 90
3 Ministry of Health, Annual Report 2013, Page 12
[1] Fourth Population and Housing Census, Rwanda 2012,Page 26
[2] Fourth Population and Housing Census, Rwanda 2012, Page 90
© 2013-2020 Sophar Ltd - All rights reserved | Mentions légales | Liens